{
    "code": "52027899",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027899",
    "time": "2021-10-08 03:36:23",
    "許可證字號": "衛部藥輸字第027899號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/06\/02",
    "發證日期": "109\/06\/02",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202789906",
    "中文品名": "韋如意凍晶乾燥注射劑100毫克\/瓶",
    "英文品名": "Veklury Lyophilized Powder for Injection 100 mg\/ Vial",
    "適應症": "適用於治療必須住院之成人與兒童病人(12歲(含)以上且體重至少40公斤)的2019冠狀病毒疾病(COVID-19)。僅可於醫院或可提供類似住院照護之急性照護的醫療照護機構內投予。",
    "劑型": "245凍晶乾燥注射劑",
    "包裝": "注射瓶裝，100支下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "新成分",
    "監視期限": "",
    "主成分略述": "Remdesivir",
    "限制項目": "02輸　入 1D須執行風險管理計畫",
    "申請商名稱": "620117L277  香港商吉立亞醫藥有限公司台灣分公司",
    "申請商地址": "臺北市信義區松仁路32號10樓之1、36號10樓之1",
    "主製造廠": [
        {
            "": "FRANCE",
            "製程": "成品及包裝廠"
        },
        {
            "": "ITALY",
            "製程": "成品及包裝廠"
        },
        {
            "": "PORTUGAL",
            "製程": "成品及包裝廠"
        },
        {
            "": "UNITED STATES",
            "製程": "成品及包裝廠"
        },
        {
            "": "UNITED STATES",
            "製程": "成品及包裝廠"
        },
        {
            "": "UNITED STATES",
            "製程": "成品及包裝廠"
        },
        {
            "": "UNITED STATES",
            "製程": "成品及包裝廠"
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FIE0060000  GILEAD SCIENCES IRELAND UC",
            "製造廠廠址": "IDA BUSINESS &amp; TECHNOLOGY PARK, CARRIGTOHILL COUNTY CORK, IRELAND",
            "製造廠公司地址": "",
            "製造廠國別": "IRELAND",
            "製程": "包裝"
        },
        {
            "製造廠名稱": "FIE0102100  MILLMOUNT HEALTHCARE LTD.",
            "製造廠廠址": "BLOCK-7, CITY NORTH BUSINESS CAMPUS STAMULLEN, CO MEATH IRELAND",
            "製造廠公司地址": "",
            "製造廠國別": "IRELAND",
            "製程": "包裝"
        },
        {
            "製造廠名稱": "FUS1160000  GLIEAD SCIENCES, INC.",
            "製造廠廠址": "1800 WHEELER AVENUE LA VERNE, CA 91750 USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "包裝"
        },
        {
            "製造廠名稱": "FUS2401000  AndersonBrecon Inc",
            "製造廠廠址": "4545 ASSEMBLY DRIVE, ROCKFORD, IL 61109 USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "包裝"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0800001000",
            "成分名稱": "Remdesivir",
            "含量描述": "This product contains 5% overage of the labeled amount, and the amount of each ingredient correspond to the actual filled amount is shown in the above.",
            "含量": "100.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "0818-VEKLURY韋如意凍晶乾燥注射劑100mg 中文仿單-29.7x38cm-110-08-31.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027899&Seq=005&Type=9"
        },
        {
            "title": "韋如意 醫療人員指引_10AUG2020-109-08-11.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027899&Seq=003&Type=9"
        },
        {
            "title": "韋如意 病人用藥須知_10AUG2020-109-08-11.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027899&Seq=002&Type=9"
        },
        {
            "title": "027899 凍晶乾燥 標籤 artwork-export-label-powderforsolution-109-07-09.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027899&Seq=002&Type=8"
        },
        {
            "title": "027899 凍晶乾燥 外盒 artwork-export-carton-powderforsolution-109-07-09.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027899&Seq=001&Type=8"
        }
    ]
}